FDA Drug Recalls

Recalls / Active ingredient / Eletriptan Hydrobromide

Eletriptan Hydrobromide

3 FDA drug recalls involving the active ingredient “Eletriptan Hydrobromide”.

DateClassProductFirm
2021-03-15Class IIEletriptan Hydrobromide Tablets 20 mg* 6(1x6) Unit-dose Tablets Rx only NDC 59651-104-69 Distributed by: AurobCardinal Health Inc.
2019-08-14Class IIRELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-Pfizer Inc.
2019-04-29Class IIIRelpax (eletriptan HBr) 40 mg, a) 12 tablets 2 cards x six 40 mg tablets per blister pack, NDC 0049-2340-05; bPfizer Inc.